Biotech · Public company · New Haven, CT, US

Invivyd, Inc.

Ticker IVVD · SEC CIK 0001832038

Track this companyFree. Adds Invivyd, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials41 recruiting or active

Pipeline programs6From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline6

Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 VaccinePHASE3 · COMPLETED · started Jun 8, 2026ClinicalTrials.gov NCT07655180 · fetched Nov 12, 2026
Study of VYD2311 for the Prevention of COVID-19PHASE3 · ACTIVE_NOT_RECRUITING · started Jan 8, 2026ClinicalTrials.gov NCT07298434 · fetched Nov 12, 2026
A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2PHASE3 · COMPLETED · started Sep 8, 2023ClinicalTrials.gov NCT06039449 · fetched Nov 12, 2026
Evaluation of ADG20 for the Prevention of COVID-19PHASE2_PHASE3 · TERMINATED · started Apr 27, 2021ClinicalTrials.gov NCT04859517 · fetched Nov 12, 2026